63323-467 : Sensorcaine 5 mg/ml Perineural Injection, Solution


NDC: 63323-467
Labeler: App Pharmaceuticals, LLC
Product Type: Human Prescription Drug
Drug Name:  Sensorcaine
Dosage Form: Perineural Injection, Solution
Application #: ANDA018304
Rev. Date: 


NDC Package Codes:

  • 63323-467-57: 25 VIAL, MULTI‑DOSE IN 1 TRAY (63323‑467‑57) > 50 ML IN 1 VIAL, MULTI‑DOSE

Active Ingredients:

  • Bupivacaine Hydrochloride

Dosage Strength:

  • 5 mg/mL

Pharmaceutical Classes:

  • Amide Local Anesthetic [EPC]
  • Amides [Chemical/Ingredient]
  • Local Anesthesia [PE]

Related Products:

Based on records with the same trade name.
  • 63323-461 Sensorcaine Infiltration; Perineural Injection, Solution by App Pharmaceuticals, LLC
  • 63323-463 Sensorcaine Perineural Injection, Solution by App Pharmaceuticals, LLC
  • 63323-465 Sensorcaine 2.5 mg/ml Infiltration; Perineural Injection, Solution by App Pharmaceuticals, LLC
  • 0404-9945 Sensorcaine 2.5 mg/ml Infiltration; Perineural Injection, Solution by Henry Schein, Inc.
  • 0404-9947 Sensorcaine 5 mg/ml Perineural Injection, Solution by Henry Schein, Inc.
  • 52584-465 Sensorcaine 2.5 mg/ml Infiltration; Perineural Injection, Solution by General Injectables & Vaccines, Inc
  • 52584-467 Sensorcaine 5 mg/ml Perineural Injection, Solution by General Injectables & Vaccines, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 63323-467 QR Code

< Prev: 63323-466Next: 63323-468 >

Related Discussions:

sterilisation of bupivacaine
Hello, I am in search of information on the stability of the bupivacaine sterilized with the gamma rays.Do you know if t...




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.